The executive committee of Johnson & Johnson is responsible for the strategic operations and allocation of the company's resources, overseeing and coordinating the activities of its business segments. The company competes with other companies both locally and globally, with competition in research, development, and improvement of new and existing products and processes being particularly significant. The competitive environment necessitates substantial investments in continuing research and the development of innovative products, which is critical to the company's success. Management emphasizes the importance of leveraging extensive resources across the enterprise to innovate and execute with excellence, ensuring the company remains focused on addressing unmet societal needs and investing for enduring impact. The company has committed $14.7 billion to research and development, reflecting its dedication to creating life-enhancing innovations and value through partnerships. The company’s ability to mobilize and deploy IT-based resources, combined with leveraging other resources and capabilities, is essential for transforming into a competitive force. The company has implemented actions across its global supply chain to enhance agility and drive growth, which includes expanding the use of strategic collaborations and optimizing its network. The company’s operational flexibility is supported by robust business continuity plans, enabling it to meet the demands of rapidly evolving markets. The company continues to monitor its internal and external supply arrangements, ensuring adequate distribution and effective management of critical inventory. Additionally, the company has established a global vaccine supply network, which is part of its strategy to leverage technology and resources for operational efficiency. The company’s commitment to innovation is further demonstrated through its investments in digital technologies and the development of new products, which accounted for approximately 25% of 2021 sales. The company has also recognized the importance of information management capability, ensuring the provision of data and information to users with appropriate levels of accuracy, timeliness, reliability, and security. The company’s strategic resource allocation and investment decisions are guided by its objectives to create value and enhance organizational capabilities, which are crucial for sustaining competitive advantage in the healthcare industry. The company’s focus on operational efficiency and process optimization is evident in its restructuring programs aimed at generating significant annual pre-tax cost savings. The company’s ability to adapt to market dynamics and external influences is critical for maintaining its competitive positioning and achieving performance excellence. The company’s strategic management practices are designed to enhance organizational effectiveness and agility, enabling it to respond to environmental factors and shifting capacities. The company’s approach to managing its technology portfolio and infrastructure capabilities is integral to its overall business strategy, ensuring alignment with organizational goals and market-based performance.